Series B startups in Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Laza Medical | Pfaffikon | Series B | $160.0M | 2026-11-04 |
| NovaGo Therapeutics | Schlieren | Series B | $29.7M | 2026-08-31 |
| Vaderis Therapeutics | Basel | Series B | $152.0M | 2026-08-11 |
| Windward Bio | Basel | Series B | $165.0M | 2026-05-04 |
| KEMARO AG | Eschlikon | Series B | $5.0M | 2026-04-23 |
| Delvitech | Mendrisio | Series B | $40.0M | 2025-11-11 |
| deskbird | Pfaffikon | Series B | $23.0M | 2025-09-24 |
| Loft Dynamics | Zürich | Series B | $24.0M | 2025-08-21 |
8 rows of the CSV in 5 of its 18 columns.
- The 124 series b startups in Switzerland have raised $3.6B in total.
- 10 of them closed their most recent round in the last 12 months, $601.3M combined.
- The largest of those rounds is Windward Bio's $165.0M Series B, dated May 2026.
- The most recent is Laza Medical's $160.0M Series B on 4 November 2026.
- Venture Kick is an investor in 14 of them, more than any other fund.
- Software is the most common sector, with 56 companies (45%).
- 11% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 11 to 50 employees (43% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 124| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| KEMARO AG | KEMARO AG engineers autonomous robotics. | Artificial intelligence | Eschlikon | Series B | $5.0M | 2026-04-23 | $10.4M | Innosuisse, Spicehaus Partners | 11 to 50 | 2016 |
| Delvitech | Delvitech develops sustainable AI-based 3D automated optical inspection solutions for microelectronics. | Artificial intelligence | Mendrisio | Series B | $40.0M | 2025-11-11 | $48.6M | TiVentures, Credit Suisse Entrepreneur Capital | 51 to 100 | 2018 |
| Loft Dynamics | Loft Dynamics develops virtual reality flight simulators for realistic, affordable, and safe pilot training. | Education | Zürich | Series B | $24.0M | 2025-08-21 | $53.3M | Craft Ventures, UP Ventures | 51 to 100 | 2016 |
| Zama | Zama provides confidentiality for public blockchains. | Cybersecurity | Zug | Series B | $57.0M | 2025-06-25 | $139.3M | Plug and Play, Protocol Labs, Metaplanet +2 | 51 to 100 | 2020 |
| GlycoEra | GlycoEra researches and produces extracellular protein degraders for treating autoimmune diseases. | Biotech | Wädenswil | Series B | $130.0M | 2025-05-27 | $179.3M | Sofinnova Partners, Bristol-Myers Squibb, 5AM Ventures +1 | 11 to 50 | 2020 |
| amnis | amnis helps businesses cut international transaction costs, manage team spending, and handle daily accounting. | Fintech | Zürich | Series B | $11.2M | 2025-02-26 | $22.8M | Spicehaus Partners, Lansdowne Partners | 11 to 50 | 2014 |
| Sparta | Sparta helps traders identify market opportunities with clarity and confidence. | Energy | Geneva | Series B | $42.0M | 2025-02-24 | $65.5M | FirstMark, Singular | 101 to 250 | 2020 |
| Embotech | Embotech provides Level 4 autonomous driving solutions built for industrial logistics applications. | Software | Zürich | Series B | $26.3M | 2024-12-12 | VentureOut, European Innovation Council, FuturePlay | 101 to 250 | 2013 | |
| Noema Pharma | Noema Pharma develops therapies that treat disabling symptoms of brain and nervous system conditions. | Biotech | Basel | Series B | $147.2M | 2024-12-11 | $316.5M | Polaris Partners, Sofinnova Partners, Invus +2 | 11 to 50 | 2019 |
| Wyden | Wyden is a fintech company that provides digital asset trading services for institutions and asset managers. | Fintech | Zürich | Series B | $16.9M | 2024-11-12 | Verve Ventures, FinLab, Groundshift +1 | 51 to 100 | 2014 | |
| Retinai | RetinAI is a company that simplifies clinic, research, and pharmaceutical workflows to improve healthcare. | Artificial intelligence | Bern | Series B | $7.8M | 2024-10-16 | $16.8M | Venture Kick, Verve Ventures, Matterwave Ventures | 11 to 50 | 2016 |
| CorFlow Therapeutics | CorFlow Therapeutics develops proprietary technologies to diagnose and treat microvascular obstructions. | Biotech | Baar | Series B | $48.5M | 2024-09-10 | $66.1M | Innosuisse, Unorthodox Ventures, Panakes Partners +2 | 11 to 50 | 2016 |
| iOnctura | iOnctura is a clinical-stage biotechnology company developing treatments for cancer. | Biotech | Geneva | Series B | $85.7M | 2024-06-20 | European Innovation Council, M Ventures, VI Partners +2 | 11 to 50 | 2017 | |
| Hemotune | Hemotune develops a therapeutic blood purification platform for treating health conditions. | Biotech | Schlieren | Series B | $15.6M | 2024-03-25 | Venture Kick, Innosuisse, Gebert Rüf Stiftung | 11 to 50 | 2016 | |
| Taurus | Taurus provides banking-grade digital asset infrastructure for issuing, custodying, and trading digital assets globally. | Fintech | Geneva | Series B | $65.0M | 2023-02-13 | Deutsche Bank, Credit Suisse, Cedar Mundi Ventures | 101 to 250 | 2018 | |
| Ledgy | Ledgy is a software company that helps organizations manage equity compensation compliantly and at scale. | Fintech | Zürich | Series B | $22.0M | 2022-09-21 | $33.4M | Sequoia Capital, New Enterprise Associates, Speedinvest +2 | 51 to 100 | 2017 |
| Sonar Unicorn | Sonar provides a verification layer for AI and agentic coding along with automated code review. | Artificial intelligence | Vernier | Series B | $412.0M | 2022-04-26 | $457.0M | Insight Partners, General Catalyst, Advent International +1 | 501 to 1,000 | 2008 |
| Aeris Health | Aeris Health provides smart solutions for monitoring and improving indoor air quality. | Health care | Zug | Series B | $8.5M | 2021-03-01 | $12.8M | PreAngel, Sarona Ventures | 11 to 50 | 2014 |
| Crypto Finance Group | Crypto Finance provides regulated digital asset and blockchain services to institutional clients. | Fintech | Zug | Series B | $14.4M | 2020-04-16 | Lingfeng Capital, QBN Capital | 101 to 250 | 2017 | |
| algrano | Algrano is a multi-sided platform that lets coffee producers sell directly to the processing industry. | Commerce | Zürich | Series B | $4.0M | 2019-12-06 | Start-Up Chile, SICTIC, Founderful +2 | 11 to 50 | 2015 | |
| MaxiVAX | MaxiVAX is a Swiss clinical-stage biotechnology company. | Biotech | Geneva | Series B | $5.0M | 2019-11-27 | EIC Accelerator | 1 to 10 | 2005 | |
| Amal Therapeutics | Amal Therapeutics SA is a privately held Swiss and German biotech startup spun off from the University of Geneva. | Biotech | Geneva | Series B | $32.6M | 2018-11-12 | HTGF (High-Tech Gruenderfonds), Venture Kick, VI Partners +2 | 11 to 50 | 2012 | |
| Therachon | Therachon is a global biotechnology company developing medicines for rare genetic diseases. | Biotech | Basel | Series B | $60.0M | 2018-08-09 | $100.0M | Bpifrance, New Enterprise Associates, OrbiMed +2 | 1 to 10 | 2014 |
| Muume | Muume is an all-in-one device that helps small businesses build and manage their online presence. | Fintech | Zug | Series B | $6.2M | 2017-08-22 | Heliad AG | 101 to 250 | 2013 | |
| Coorpacademy | Coorpacademy offers learning solutions and MOOCs. | Education | Lausanne | Series B | $10.9M | 2016-10-26 | Serena, Debiopharm Innovation Fund, NextStage | 11 to 50 | 2013 | |
| KB Medical | KB Medical is a Swiss company that designs, develops, and commercializes the AQrate robotic system. | Hardware | Lausanne | Series B | $2.5M | 2016-10-25 | Venture Kick, Foundation for Innovation and Technology (FIT), Kinled Holding | 1 to 10 | 2012 |
Table 1. Series B startups in Switzerland: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 124.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Windward Bio | Windward Bio develops monoclonal antibodies for advanced immunological diseases. | Biotech | Basel | Series B | $165.0M | 2026-05-04 | $365.0M | Qiming Venture Partners, OrbiMed, Novo Holdings +2 | 11 to 50 | 2024 |
| 2 | Laza Medical | Laza Medical produces AI-powered robotic imaging systems for cardiovascular treatments. | Artificial intelligence | Pfaffikon | Series B | $160.0M | 2026-11-04 | $196.0M | Page One Ventures, Unorthodox Ventures, The Capital Partnership | 1 to 10 | 2020 |
| 3 | Vaderis Therapeutics | Vaderis Therapeutics develops targeted therapies for rare vascular diseases in clinical trials. | Biotech | Basel | Series B | $152.0M | 2026-08-11 | $170.6M | Medicxi | 11 to 50 | 2019 |
| 4 | NovaGo Therapeutics | NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration after cerebral stroke. | Biotech | Schlieren | Series B | $29.7M | 2026-08-31 | $39.7M | Kinled Holding, Pureos Bioventures | 1 to 10 | 2015 |
| 5 | KEMARO AG | KEMARO AG engineers autonomous robotics. | Artificial intelligence | Eschlikon | Series B | $5.0M | 2026-04-23 | $10.4M | Innosuisse, Spicehaus Partners | 11 to 50 | 2016 |
Table 2. Series B startups in Switzerland: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Venture Kick | Startup incubator | Schlieren, Switzerland | 14 | 11% | ||
| 2 | Verve Ventures | Venture capital firm | Zug, Switzerland | 10 | 8% | ||
| 3 | VI Partners | Venture capital firm | Altendorf, Switzerland | 6 | 5% | ||
| 4 | Innosuisse | Government investment office | Berne, Switzerland | 5 | 4% | 1 | KEMARO AG |
| 5 | Sofinnova Partners | Venture capital firm | Paris, France | 3 | 2% | ||
| 6 | European Innovation Council | Startup accelerator | Brussels, Belgium | 3 | 2% | ||
| 7 | Founderful | Venture capital firm | Zürich, Switzerland | 3 | 2% | ||
| 8 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | 3 | 2% | ||
| 9 | Swisscom Ventures | Venture capital firm | Zürich, Switzerland | 3 | 2% | ||
| 10 | BioMedPartners | Venture capital firm | Basel, Switzerland | 3 | 2% | ||
| 11 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 3 | 2% | ||
| 12 | Unorthodox Ventures | Family office | Austin, United States | 2 | 2% | 1 | Laza Medical |
| 13 | Kinled Holding | Private equity firm | New York, United States | 2 | 2% | 1 | NovaGo Therapeutics |
| 14 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 2 | 2% | 1 | Windward Bio |
| 15 | OrbiMed | Private equity firm | New York, United States | 2 | 2% | 1 | Windward Bio |
Table 3. Series B startups in Switzerland: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 56 | 45% | $1.4B |
| Health care | 51 | 41% | $2.4B |
| Biotech | 31 | 25% | $1.6B |
| Hardware | 18 | 15% | $156.0M |
| Fintech | 17 | 14% | $86.2M |
| Artificial intelligence | 12 | 10% | $821.2M |
| Commerce | 8 | 6% | $27.3M |
| Education | 4 | 3% | $53.3M |
| Cybersecurity | 3 | 2% | $144.4M |
| Energy | 3 | 2% | $65.5M |
Table 4. Series B startups in Switzerland by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 124 | 100% | $16.9M |
Table 5. Series B startups in Switzerland by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Zürich | 34 | 27% |
| Geneva | 14 | 11% |
| Zug | 11 | 9% |
| Basel | 9 | 7% |
| Schlieren | 6 | 5% |
| Lausanne | 6 | 5% |
| Bern | 4 | 3% |
| Pfaffikon | 3 | 2% |
| Vaud | 3 | 2% |
| Neuchâtel | 2 | 2% |
| Epalinges | 2 | 2% |
| Chiasso | 1 | 1% |
Table 6. Series B startups in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 10% | $160.0M |
| August 2026 | 2 | 20% | $181.7M |
| July 2026 | 2 | 20% | $38.0M |
| June 2026 | 1 | 10% | $18.0M |
| May 2026 | 2 | 20% | $198.6M |
| April 2026 | 1 | 10% | $5.0M |
| March 2026 | 1 | 10% |
Table 7. Series B startups in Switzerland: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 10 | 8% | $601.3M |
| 2025 | 12 | 10% | $481.9M |
| 2024 | 14 | 11% | $541.5M |
| 2023 | 5 | 4% | $116.9M |
| 2022 | 10 | 8% | $527.7M |
| 2021 | 9 | 7% | $171.6M |
Table 8. Series B startups in Switzerland by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 2% |
| 2020 to 2022 | 12 | 10% |
| 2015 to 2019 | 41 | 33% |
| 2010 to 2014 | 39 | 31% |
| Before 2010 | 30 | 24% |
Table 9. Series B startups in Switzerland by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 24 | 20% |
| 11 to 50 | 53 | 43% |
| 51 to 100 | 22 | 18% |
| 101 to 250 | 20 | 16% |
| 501 to 1,000 | 1 | 1% |
| 1,001 to 5,000 | 3 | 2% |
Table 10. Series B startups in Switzerland by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series B and its headquarters is in Switzerland. On 16 November 2026 that is 124 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 124 rows: 25 have no round amount, 0 no city and 61 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series b startups in Switzerland are on the list?
- 124, in the file dated 16 November 2026. 10 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 124 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.